ProMIS Neurosciences Announces First Quarter 2022 Results :

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

United States , United Kingdom , Massachusetts , Saskatchewan , Manitoba , Canada , Montreal , Quebec , Cambridge , Cambridgeshire , Toronto , Ontario , Spain , Barcelona , Comunidad Autonoma De Cataluna , American , British , Larry Altstiel , Carsten Korth , Nicholas Rigopulos , Alain Dagher , Neil Cashman , Gene Williams , David Wishart , Guy Rouleau , Justin Yerbury , Michelle Hastings , University Of Saskatchewan Vaccine , Department Of Neurology , Linkedin , Twitter , Good Laboratory Practice , Tanenbaum Open Science Institute , Pfizer , Neurosurgery Of Mcgill University , University Of California San Diego , University Of British Columbia , Laboratory Medicine , Neuro Montreal Neurological Institute , Promis Neurosciences Inc , Toronto Stock Exchange , Infectious Disease Organization , American Academy Of Neurology , Chief Medical Officer , Potential Next Generation Therapy , Good Manufacturing Practice , British Columbia , Gene Yeo , California San Diego , American Academy , Associated Global Translational Suppression , Saskatchewan Vaccine , Chief Physics Officer , Scientific Advisory , Molecular Neuropathology , Cheryl Wellington , Montreal Neurological Institute Hospital , Mcgill University , Mcgill University Health Centre , Tanenbaum Open Science , Montreal Neurological , Chief Medical , Months Ended March , North American , Collective Coordinates , Disease Specific Epitopes , Investor Relations , Technology , Health , Globe Newswire , Mental Health , Clinical Trials , Biotechnology , Schizophrenia ,